Astra Joint Venture Keeps Paying Dividends For Merck; “True Up” Due In 2008
AstraZeneca is still estimating that its final payment in the break-up of the Merck joint venture will be $4.7 bil. in 2008
AstraZeneca is still estimating that its final payment in the break-up of the Merck joint venture will be $4.7 bil. in 2008